Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Johnson & Johnson, a leading name in the research and development services sector, is headquartered in the United States. Founded in 1886, the company has established itself as a pioneer in healthcare innovation, focusing on pharmaceuticals, medical devices, and consumer health products. With a strong presence in North America, Europe, and Asia, Johnson & Johnson is renowned for its commitment to quality and safety.
The company’s core offerings include advanced medical technologies, over-the-counter consumer health products, and prescription medications, each distinguished by rigorous research and development. Notable achievements include the development of groundbreaking treatments and a robust portfolio of trusted brands. As a market leader, Johnson & Johnson continues to shape the future of healthcare through its dedication to improving patient outcomes and enhancing quality of life.
+59 vs industry average
Johnson And Johnson’s score of 92 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Johnson & Johnson, a US-based company in the Research and development services industry, has set ambitious climate commitments and reported its carbon emissions.
For 2024, Johnson & Johnson reported Scope 1 emissions of approximately 316 million kg CO2e, Scope 2 market-based emissions of approximately 123 million kg CO2e, and Scope 3 emissions of approximately 6.36 billion kg CO2e. In 2023, the company's Scope 1 emissions were about 326 million kg CO2e, Scope 2 market-based emissions were around 137 million kg CO2e, and Scope 3 emissions totalled approximately 6.55 billion kg CO2e. Looking back to 2022, Johnson & Johnson's Scope 1 emissions were approximately 333 million kg CO2e, Scope 2 market-based emissions were about 182 million kg CO2e, and Scope 3 emissions were around 6.72 billion kg CO2e.
Johnson & Johnson has committed to significant emissions reductions. The company aims to achieve carbon neutrality for its operations by 2030. Furthermore, Johnson & Johnson is targeting a 44% absolute reduction in Scope 1 and 2 GHG emissions by 2030, from a 2021 base year. They also have a near-term Science-Based Target to reduce absolute Scope 1 and 2 GHG emissions by 44% by 2030 from a 2021 base year, with a long-term goal of an 80% reduction by 2050 from a 2010 base year. Additionally, Johnson & Johnson commits that 80% of its suppliers, by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2028.
2030
44% reduction in Scope 2
Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* * The target boundary includes…
2030
44% reduction in Scope 1
Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* * The target boundary includes…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Johnson And Johnson’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more